A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it ...

Two Danish researchers faced accusations of “questionable research practices” as RFK Jr.’s top appointees made their study a “funding priority” ...

Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

The university said content of the graduate course, which was already underway, was not adequately disclosed, forcing the ...

Brain aneurysms occupy a unique and somewhat paradoxical position in cerebrovascular disease. Although unruptured aneurysms ...

Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets ...

In his recent comment, Dana Ullman asked AI to analyse my critique of a yoga study. I thought this was good fun and therefore decided to do a similar exercise. I asked AI: Dana Ullman, please ...

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Approval from HREC for Phase 1/2 Diabetic Foot Ulcer Trial In ...

Introduction Each year, millions of people experience recurrent diverticulitis episodes. Elective sigmoid colon resection reduces the risk of recurrence, but The American Society of Colon and Rectal ...

This company has just won approval to go ahead with a key clinical trial. The post This biotech is approaching 20-bagger ...

Nyrada Inc. (ASX:NYR), a clinical-stage biotechnology company focused on developing Transient Receptor Potential Canonical ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...